Recent News for HOOK - HOOKIPA Pharma Inc.

Date Title
Apr 10 HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its immunotherapy candidates to treat advanced HPV16+ cancers
Mar 18 HOOKIPA Pharma Inc. (HOOK) CEO Joern Aldag on Q4 2020 Results - Earnings Call Transcript
Mar 18 HOOKIPA Pharma shares up after Q4 beat
Mar 18 HOOKIPA Pharma Inc. (HOOK) Reports Q4 Loss, Tops Revenue Estimates
Mar 18 HOOKIPA Pharma: Q4 Earnings Insights
Mar 18 Earnings Scheduled For March 18, 2021
Mar 18 HOOKIPA Pharma EPS beats by $0.13, beats on revenue
Mar 18 HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
Mar 11 Analysts Estimate HOOKIPA Pharma Inc. (HOOK) to Report a Decline in Earnings: What to Look Out for
Mar 9 HOOKIPA Pharma To Report Fourth Quarter and Full Year 2020 Financial Results on Thursday, March 18, 2021
Mar 4 Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics published in Cell Reports Medicine
Mar 3 HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life Sciences Conference
Feb 27 Did HOOKIPA Pharma's (NASDAQ:HOOK) Share Price Deserve to Gain 19%?
Feb 16 HOOKIPA Pharma to Participate in Upcoming SVB Leerink Global Healthcare Conference
Jan 20 HOOKIPA Pharma (HOOK) in Focus: Stock Moves 8.4% Higher
Dec 31 Hookipa: Data Readouts Of 2021's HB-101, HB-201, And HB-201/-202 Hold Promising Upside
Dec 11 HOOKIPA Pharma Announces Closing of Public Offering of $80.9 Million of Common Stock and Preferred Stock, Including Full Exercise of Underwriters’ Option
Dec 9 HOOKIPA Pharma prices public offering of common stock and preferred stock
Dec 9 HOOKIPA Pharma Announces Pricing of Public Offering of Common Stock and Preferred Stock
Dec 8 HOOKIPA Pharma proposes public offering of common and preferred stock
Dec 8 HOOKIPA Pharma Announces Proposed Public Offering of Common Stock and Preferred Stock
Dec 8 HOOKIPA (HOOK) Surges: Stock Moves 8.6% Higher
Dec 8 Is HOOK A Good Stock To Buy Now?
Dec 7 Why Gamida, Scpharmaceuticals And Hookipa Are Moving Today
Dec 7 HOOKIPA Interim Phase 1 Monotherapy Data of HB-201 for the Treatment of Advanced HPV16+ Cancers Shows Promising Anti-Tumor Activity and Favorable Tolerability
Back to the Main HOOK Page...